Consolidated Balance Sheet - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Current Assets
Cash and cash equivalents	$ 12,694	$ 8,096
Short-term investments	498	0
Accounts receivable (net of allowance for doubtful accounts of $72 in 2022 and $62 in 2021)	9,450	9,230
Inventories (excludes inventories of $2,938 in 2022 and $2,194 in 2021 classified in Other assets - see Note 8)	5,911	5,953
Other current assets	7,169	6,987
Total current assets	35,722	30,266
Investments	1,015	370
Property, Plant and Equipment (at cost)
Land	295	326
Buildings	13,166	12,529
Machinery, equipment and office furnishings	16,760	16,303
Construction in progress	9,186	8,313
Property, plant and equipment (at cost)	39,407	37,471
Less: accumulated depreciation	17,985	18,192
Property, plant and equipment, net	21,422	19,279
Goodwill	21,204	21,264
Other Intangibles, Net	20,269	22,933
Other Assets	9,528	11,582
Total Assets	109,160	105,694
Current Liabilities
Loans payable and current portion of long-term debt	1,946	2,412
Trade accounts payable	4,264	4,609
Accrued and other current liabilities	14,159	13,859
Income taxes payable	1,986	1,224
Dividends payable	1,884	1,768
Total current liabilities	24,239	23,872
Long-Term Debt	28,745	30,690
Deferred Income Taxes	1,795	3,441
Other Noncurrent Liabilities	8,323	9,434
Merck & Co., Inc. Stockholders’ Equity
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2022 and 2021	1,788	1,788
Other paid-in capital	44,379	44,238
Retained earnings	61,081	53,696
Accumulated other comprehensive loss	(4,768)	(4,429)
Stockholders' equity before deduction for treasury stock	102,480	95,293
Less treasury stock, at cost: 1,039,269,638 shares in 2022 and 1,049,499,023 shares in 2021	56,489	57,109
Total Merck & Co., Inc. stockholders’ equity	45,991	38,184
Noncontrolling Interests	67	73
Total equity	46,058	38,257
Total Liabilities and Equity	$ 109,160	$ 105,694